{"filing":{"accession_number":"0001653477-26-000044","cik":"0001653477","ticker":"NGVT","company_name":"Ingevity Corp","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"ngvt-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1653477/000165347726000044/ngvt-20260729.htm"},"events":[{"id":21796,"run_id":19667,"accession_number":"0001653477-26-000044","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Ingevity announced preliminary financial results for Q2 and H1 2026 on July 29, 2026, disclosing net sales of $314.1 million, net income from continuing operations of $39.8 million ($1.13 per diluted share), and adjusted EBITDA of $115.0 million, along with raised full-year 2026 guidance. The filing explicitly states this is an earnings release attached as Exhibit 99.1, and Item 2.02 is the standard Item for results of operations and financial condition disclosures.","company_name":"Ingevity Corp","ticker":"NGVT","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21523,"accession_number":"0001653477-26-000044","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Ingevity announced preliminary financial results for Q2 and H1 2026 on July 29, 2026, disclosing net sales of $314.1 million, net income from continuing operations of $39.8 million ($1.13 per diluted share), and adjusted EBITDA of $115.0 million, along with raised full-year 2026 guidance. The filing explicitly states this is an earnings release attached as Exhibit 99.1, and Item 2.02 is the standard Item for results of operations and financial condition disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-30T00:20:42.611789+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21523,"accession_number":"0001653477-26-000044","item_number":"2.02","item_title":"RESULTS OF OPERATIONS AND FINANCIAL CONDITION","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Ingevity announced preliminary financial results for Q2 and H1 2026 on July 29, 2026, disclosing net sales of $314.1 million, net income from continuing operations of $39.8 million ($1.13 per diluted share), and adjusted EBITDA of $115.0 million, along with raised full-year 2026 guidance. The filing explicitly states this is an earnings release attached as Exhibit 99.1, and Item 2.02 is the standard Item for results of operations and financial condition disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-30T00:20:42.611789+00:00","company_name":"Ingevity Corp","ticker":"NGVT","filing_date":"2026-07-29"}]}